Growth Metrics

Sarepta Therapeutics (SRPT) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 65.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 65.26%
Dec 31, 2025 42.54%
Sep 30, 2025 79.37%
Jun 30, 2025 1,649.01%
Mar 31, 2025 -141.01%
Dec 31, 2024 268.41%
Sep 30, 2024 38.37%
Jun 30, 2024 112.22%
Mar 31, 2024 -15.61%
Dec 31, 2023 40.84%
Sep 30, 2023 -76.57%
Jun 30, 2023 -82.94%
Mar 31, 2023 -106.96%
Dec 31, 2022 -215.05%
Sep 30, 2022 47.75%
Jun 30, 2022 38.78%
Mar 31, 2022 43.91%
Dec 31, 2021 83.20%
Sep 30, 2021 47.80%
Jun 30, 2021 -1.43%
Mar 31, 2021 -128.73%
Dec 31, 2020 -6.56%
Sep 30, 2020 -253.23%
Jun 30, 2020 -36.20%
Mar 31, 2020 529.31%
Dec 31, 2019 -33.80%
Sep 30, 2019 40.49%
Jun 30, 2019 32.62%
Mar 31, 2019 -309.98%
Dec 31, 2018 -294.17%
Sep 30, 2018 -95.70%
Jun 30, 2018 -37.71%
Mar 31, 2018 38.38%
Dec 31, 2017 61.77%
Sep 30, 2017 4.47%
Jun 30, 2017 -96.72%
Mar 31, 2017 4.61%
Dec 31, 2016 -159.76%
Sep 30, 2016 -30.88%
Jun 30, 2016 -51.71%
Mar 31, 2016 -40.00%
Dec 31, 2015 -22.88%
Sep 30, 2015 -31.12%
Jun 30, 2015 27.78%
Mar 31, 2015 -53.36%
Dec 31, 2014 -42.80%
Sep 30, 2014 -77.69%
Jun 30, 2014 -229.15%
Mar 31, 2014 -88.52%
Dec 31, 2013 -148.98%
Sep 30, 2013 -154.68%
Jun 30, 2013 -111.23%
Mar 31, 2013 -65.69%
Dec 31, 2012 -26.74%
Sep 30, 2012 -3.75%
Jun 30, 2012 -1,185.52%
Mar 31, 2012 10.10%
Dec 31, 2011 -199.15%
Sep 30, 2011 -171.29%